Category: Advanced Clinical

  • The post-COVID face of pharma research and development

    The acute phase of the COVID-19 pandemic not only brought delays, restrictions, and reconfigurations to pharmaceutical research & development in 2020, but also a more flexible response to some long-standing issues with the clinical trials process.  Lockdown rules and safety protocols certainly made it harder for patients to travel to trial sites, while a refocusing […]